Eye health is MK sporta significant public health and social issue that affects people's livelihoods. Recently, at the 36th Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) Annual Meeting and the 24th Chinese Society of Cataract and Refractive Surgery (CSCRS), cataract and refractive surgery experts from the Asia-Pacific region, including the Chinese mainland, gathered in Chengdu, Southwest China's Sichuan Province, for in-depth academic exchanges.
A global leader in eye care, Alcon showcased a series of advanced ophthalmic surgical products, equipment technologies, and refractive cataract solutions during the three-day conference. The company also introduced several newly upgraded products based on the Clareon™ intraocular lens platform, leveraging its leading expertise in the ophthalmic field to enhance innovation accessibility and serve the Chinese market.
In recent years, myopia and presbyopia have become two major eye health challenges for human beings. As early as 2019, the World Health Organization released the first-ever World Vision Report, indicating that the overall prevalence of myopia is highest in high-income countries of the Asia-Pacific region, with an incidence rate of 67 percent among urban youth in China.
The Chinese Journal of Experimental Ophthalmology predicted in a report in 2023 that, as the aging population intensifies, the number of adults with cataracts in China is expected to exceed 240 million by 2050.
Rajkumar Narayanan, President International at Alcon
"The
Alcon Eye On Cataract Study, which includes the Chinese market, shows that eye health ranks among the top three health needs. This means that people, especially the elderly, have higher expectations for better vision," said Rajkumar Narayanan, President International at Alcon.
Alcon has always been committed to helping people see a brilliant world by supporting ophthalmologists with cutting-edge technology to provide high-quality visual outcomes.
"We have a highly successful intraocular lens product that has been successfully launched in China and recently participated in the NVBP (national volume-based procurement) in China, which further improves its accessibility. In the field of refractive products, our new technology can provide better-personalized solutions, which will further promote the localization of global innovations," Narayanan noted.
Constantly introducing new technologies, products, and solutions has been the development path of this company, which has a history of over 75 years. As Narayanan said, "The key to our success is product innovation."
Alcon considers talent, research and development, and investment as the three driving forces behind its innovation. The company recruits top ophthalmic talents from the industry, and spares no expense in developing better products. To win the market, Alcon established its China branch in 1995, providing high quality training and education to eyecare professionals through Alcon Experience Academy and Phaco Development programs to actively support the development of China's eye care industry.
"In addition to supporting NVBP policy and expanding accessibility in the eye health and eye care fields, we are also committed to the education and professional training of grassroots ophthalmologists," Narayanan said.
According to Narayanan, China is a leader in the digital field, with many of its digital industries at the forefront internationally. For Alcon, seizing this opportunity to build a digital ecosystem in the health sector, thereby improving the efficiency of ophthalmic medical diagnosis, surgery, and treatment outcomes, presents both a challenge and a new opportunity.
Alcon booth at APACRS
